Product Code: ETC4471049 | Publication Date: Jul 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 85 | No. of Figures: 45 | No. of Tables: 25 | |
The apheresis market in Indonesia plays a crucial role in therapeutic procedures involving the separation and removal of specific blood components. This market has seen notable growth, driven by increasing awareness of apheresis therapies for conditions like autoimmune disorders and blood-related malignancies. Technological advancements in apheresis systems are enhancing their efficiency and safety, contributing to the market`s expansion.
Apheresis procedures are gaining popularity in Indonesia due to the rising cases of various diseases, including blood disorders and autoimmune conditions. The demand is further boosted by advancements in apheresis technology, making it a crucial tool in therapeutic treatments.
The apheresis market in Indonesia faces specific challenges. One of the foremost issues is the availability of skilled healthcare professionals who can perform apheresis procedures competently. Training and education programs must be robust to ensure a sufficient workforce. Additionally, regulatory hurdles and standards for apheresis equipment and procedures need to be well-defined and enforced. The cost of apheresis procedures can also be a barrier, and healthcare providers may need to find ways to make this treatment more accessible to a broader patient population.
The Indonesia apheresis market faced challenges during the pandemic, as the focus of healthcare resources shifted toward COVID-19 treatment. Non-urgent apheresis procedures were postponed, affecting market growth. However, as healthcare services return to normal, the market is expected to recover, driven by the ongoing need for apheresis in various therapeutic applications.
The apheresis market in Indonesia has seen notable advancements, driven by companies such as Fresenius Kabi, Haemonetics Corporation, and Terumo BCT. These key players have been at the forefront of developing apheresis technologies for therapeutic and donor apheresis procedures. Their innovative devices have played a crucial role in treating various medical conditions, including autoimmune disorders, hematological diseases, and organ transplantations.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Apheresis Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Apheresis Market Revenues & Volume, 2021 & 2031F |
3.3 Indonesia Apheresis Market - Industry Life Cycle |
3.4 Indonesia Apheresis Market - Porter's Five Forces |
3.5 Indonesia Apheresis Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Indonesia Apheresis Market Revenues & Volume Share, By Method, 2021 & 2031F |
3.7 Indonesia Apheresis Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.8 Indonesia Apheresis Market Revenues & Volume Share, By Component, 2021 & 2031F |
3.9 Indonesia Apheresis Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Indonesia Apheresis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Indonesia Apheresis Market Trends |
6 Indonesia Apheresis Market, By Types |
6.1 Indonesia Apheresis Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Apheresis Market Revenues & Volume, By Product, 2021-2031F |
6.1.3 Indonesia Apheresis Market Revenues & Volume, By Devices, 2021-2031F |
6.1.4 Indonesia Apheresis Market Revenues & Volume, By Disposable and Reagents, 2021-2031F |
6.1.5 Indonesia Apheresis Market Revenues & Volume, By Software, 2021-2031F |
6.2 Indonesia Apheresis Market, By Method |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Apheresis Market Revenues & Volume, By Centrifugation, 2021-2031F |
6.2.3 Indonesia Apheresis Market Revenues & Volume, By Membrane Separation, 2021-2031F |
6.2.4 Indonesia Apheresis Market Revenues & Volume, By Selective Adsorption, 2021-2031F |
6.3 Indonesia Apheresis Market, By Procedure |
6.3.1 Overview and Analysis |
6.3.2 Indonesia Apheresis Market Revenues & Volume, By Donor/Automated Apheresis, 2021-2031F |
6.3.3 Indonesia Apheresis Market Revenues & Volume, By Therapeutic Apheresis, 2021-2031F |
6.4 Indonesia Apheresis Market, By Component |
6.4.1 Overview and Analysis |
6.4.2 Indonesia Apheresis Market Revenues & Volume, By Plasma (Plasmapheresis), 2021-2031F |
6.4.3 Indonesia Apheresis Market Revenues & Volume, By Platelets (Plateletpheresis), 2021-2031F |
6.4.4 Indonesia Apheresis Market Revenues & Volume, By Leukocytes (Leukapheresis or leukopheresis), 2021-2031F |
6.4.5 Indonesia Apheresis Market Revenues & Volume, By Lymphocytes (Lymphopheresis or lymphapheresis), 2021-2031F |
6.4.6 Indonesia Apheresis Market Revenues & Volume, By RBC's (Erythropheresis), 2021-2031F |
6.5 Indonesia Apheresis Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Indonesia Apheresis Market Revenues & Volume, By Blood Centers, 2021-2031F |
6.5.3 Indonesia Apheresis Market Revenues & Volume, By Hospitals, 2021-2031F |
6.5.4 Indonesia Apheresis Market Revenues & Volume, By Other End Users, 2021-2031F |
7 Indonesia Apheresis Market Import-Export Trade Statistics |
7.1 Indonesia Apheresis Market Export to Major Countries |
7.2 Indonesia Apheresis Market Imports from Major Countries |
8 Indonesia Apheresis Market Key Performance Indicators |
9 Indonesia Apheresis Market - Opportunity Assessment |
9.1 Indonesia Apheresis Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Indonesia Apheresis Market Opportunity Assessment, By Method, 2021 & 2031F |
9.3 Indonesia Apheresis Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.4 Indonesia Apheresis Market Opportunity Assessment, By Component, 2021 & 2031F |
9.5 Indonesia Apheresis Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Indonesia Apheresis Market - Competitive Landscape |
10.1 Indonesia Apheresis Market Revenue Share, By Companies, 2024 |
10.2 Indonesia Apheresis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |